Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acute disseminated encephalomyelitis
acute disseminated encephalomyelitis, multiphasic
adenylate kinase 5 autoantibodies
advances in neurology
afebrile
affect, flat
aggression
agitation
alternative medicine
alveolar hypoventilation
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amnesia
amnesia, anterograde
amygdala
amygdalohippocampectomy
amyloid beta protein
amyloid imaging
amyloid plaques
ANA
angiography, cerebral
anti Hu antibody
anti Ro antibody
anticonvulsants
anticonvulsants, effectiveness
anticonvulsants, selection of
anticonvulsants, untoward effects of
antiviral agents
anxiety
aphasia
apolipoprotein E
arrhythmia, cardiac
arteriovenous malformation
arteriovenous malformation, cerebral
astrocytoma
asymptomatic
ataxia
ataxia, cerebellar
atypical
aura
autism
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autoimmune GFAP astrocytopathy
automatisms
autonomic dysfunction
B cell lymphoma
Babinski sign
barbiturate anesthesia
basal ganglia
basal ganglia, lesion of
behavior
behavior, combative
behavioral disorder
biologic markers
blindness
blindness, sudden
brain atrophy
brain biopsy
brain volume
brainstem, lesion of
burst suppression pattern, electroencephalogram
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, metrizamide
cavernous hemangioma
CD19-directed chimeric antigen receptor T-cell therapy
central nervous system, infection of
cerebellar lesion
cerebellar pontine angle
cerebellar pontine angle tumor
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
chemotherapy, CNS treatment and complications with
children
Clinical Pathologic Conference(C.P.C.)
cognition
coma
coma, medically induced
complications
confusion
confusional state, acute
corpus callosotomy
corpus callosum
corpus callosum, lesion of
cortical dysplasia, focal
cortical resection
cost effectiveness
cytokine release syndrome
cytomegalovirus infection
deep gray nuclei
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, frontotemporal
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diagnostic criteria
diarrhea
diet
differential diagnosis
diplopia
disability, neurological
disorientation
drowsiness
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, video monitoring with
encephalitis
encephalitis, autoimmune
encephalitis, focal
encephalitis, unknown etiology
encephalitis, viral
encephalomalacia
encephalomyelitis
encephalopathy
encephalopathy, acute
encephalopathy, limbic
encephalopathy, post traumatic
epilepsy
epilepsy monitoring unit
epileptic encephalopathy
episodic disorders
episodic neurologic deficits
eye movement, disorders of
face, numbness of
facial asymmetry
facial weakness
familial
febrile infection-related epilepsy syndrome
fever
flu-like illness
gammaglobulin therapy, intravenous
gender
Geschwind, Norman
GFAP-IgG
glioma
gliomatosis cerebri
gliosis
glutamic acid decarboxylase, antibody
glyphosate
gray matter
hallucination
hallucination, auditory
hamartoma
head injury
head injury, prognosis in
headache
headache, recurrent
hemimyoclonic jerks
hemiparesis
hemispherectomy
heralding manifestation
herbicide
herpes simplex encephalitis
hiccoughs
hippocampal atrophy
hippocampus
hippocampus, hyperintense
histopathology
human herpesvirus 6
hyperactivity
hypersomnia
hyponatremia
hypothalamus, lesion of
hypothyroidism
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunohistochemistry
immunologic disease
immunosuppression
immunosuppressive agents
immunotherapy
inattention
incidentaloma
inclusion bodies
inclusion bodies, intracytopasmic
infection
insular cortex
insular cortex, lesion
insular cortex, lesion, bilateral
intellectual deficit
intellectual deterioration
ketogenic diet
learning disability
learning disability, in children
lethargy
leucine rich glioma inactivated 1 antibodies
leukopenia
level of consciousness
level of consciousness, decreased
limbic encephalitis
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lobar atrophy
lymphadenopathy, hilar
lymphoma
lymphoma, systemic
malformation, vascular
malformation, vascular, cerebral
malignancy screen
memory, defect of recent
memory, evaluation of
memory, impairment of
meningeal enhancement
meningioma
meningitis
meningitis, neurologic aspects and complications of
meningitis, seizures with
meningoencephalomyelitis
mental retardation
mesial temporal lobe
mesial temporal lobe epilepsy
mesial temporal sclerosis
mesial temporal sclerosis, bilateral
microhemorrhage, intracerebral
microinfarcts
midbrain, lesion of
middle cerebellar peduncle, lesion
mild cognitive impairment
mimics
misdiagnosis
mitochondrial disease
mortality
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, abnormal, seizure causing
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, field strength, high
MRI, FLAIR
MRI, functional
MRI, gyral enhancement
MRI, head injury
MRI, incidental finding
MRI, indications for
MRI, morphometyry
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, spinal cord
MRI, volumetry
MRI, voxel-based morphometry
MRS
multiple sclerosis
multiple sclerosis, misdiagnosis
multiple subpial transection
myelitis, longitudinal
myoclonic jerks
myoclonus
negative
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal migration disorder
neuropathology
neuropathology, brain
neuropathy
neurosyphilis
neurotoxin
NMDA antagonists
NMDA receptors
normal
nystagmus
nystagmus, primary position of gaze
ocular dipping
old age, neurology of
optic chiasm
optic chiasm, lesion of
pain
pain, leg
pallor
paranoia
Parkinsonism syndrome
periaqueductal lesion
perseveration
personality change
personality disorder
plasmapheresis
PLEDs
PLEDs, bilateral independent
PLEDs, etiology of
pleocytosis of cerebrospinal fluid
posterior fossa, lesion of
postictal neurologic deficits
postictal psychosis
potassium channel antibodies
precipitating factors
preclinical
prevention of neurologic disorders
prognosis
progressive neurologic disorder
prosopagnosia
psychiatric problems in neurologic disorders
psychological testing
psychosis
psychosurgery
psychotic behavior
pulmonary nodules
quadrantanopsia, superior
quadriparesis
rapidly progressing neurologic illness
recurrent
release phenomena
religiosity
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rheumatoid arthritis factor(R.A.factor)
risk factors
salivation, excessive
schizophrenia
screening
sedimentation rate, elevated
seizure
seizure, adult onset
seizure, children
seizure, classification of
seizure, complications following
seizure, diagnosis of
seizure, drug resistance
seizure, elderly
seizure, equivalents
seizure, etiology of
seizure, febrile
seizure, febrile, risk of epilepsy following
seizure, focal
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, new onset
seizure, prevention of
seizure, prognosis in adults
seizure, prognosis in childhood
seizure, psychomotor-frontal lobe
seizure, psychomotor-temporal lobe
seizure, psychomotor-temporal lobe, interictal behavior
seizure, psychomotor-temporal lobe, prognosis of
seizure, psychosocial aspects of
seizure, recurrent
seizure, risk factors for
seizure, surgical treatment of
seizure, treatment of
seizure, treatment of, polytherapy
seizure, treatment, adjunctive therapy
seizure, workup of
serologic testing
serologic testing of cerebrospinal fluid
seronegative
sexual behavior, disorder of
single photon emission computed tomography
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
sleep
small vessel disease
speech disorder
speech, slowed
standing difficulty
stare
status epilepticus
status epilepticus, intractable
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
subacute sclerosing panencephalitis, adult onset
subinsular cortex
symmetric brain lesions
syphilis, diagnosis and treatment
syphilis, neurologic complications with
tau protein
TDP-43 proteinopathy
temporal horn, enlarged
temporal lobe
temporal lobe, atrophy
temporal lobe, lesion
temporal lobe, lesion, bilateral
temporal lobe, status
temporal lobe, tumor
temporal lobectomy
temporal lobectomy, complications
teratoma
teratoma, ovarian
thalamus, lesion of
thyroid function tests
thyroiditis
tonic spasms
toxic encephalopathy
transient neurologic deficit
treatment of neurologic disorder
tremor
tuberous sclerosis
vaccination, neurologic complications with
vagus nerve stimulation
vasculopathy
ventricular enlargement
violent behavior
viral infection, CNS
visual field defect
visual loss
visual loss, sudden
water channel antibodies
weight loss
whistling
white matter disease
word-finding difficulty
workup
Showing articles 1050 to 1100 of 2500 << Previous Next >>

A Comparison of Continuous Thalamic Stimulation and Thalamotomy for Suppression of Severe Tremor
NEJM 342:461-468,505, Schuurman,P.R.,et al, 2000

Amnesic Syndrome with Bilateal Mesial Temporal Lobe Involvement in Hashimoto's Encephalopathy
Neurol 54:737-739, McCabe,D.J.H.,et al, 2000

Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000

Total Brain N-Acetylaspartate, A New Measure of Disease Load in MS
Neurol 54:15-19, Gonen,O.,et al, 2000

Diagnostic Criteria for Primary Progressive Multiple Sclerosis: A Position Paper
Ann Neurol 47:831-835, Thompson,A.J.,et al, 2000

Heterogeneity ofMultiple Sclerosis Lesions: Implications for the Pathogenesis of Demyelination
Ann Neurol 47:707-717, Lucchinetti,C.,et al, 2000

National Institutes of Health Consensus Conference: Tuberous Sclerosis Complex
Arch Neurol 57:662-665, Hyman,M.H.&Whittemore,V.H., 2000

Open-Ring Imaging Sign
Neurol 54:1427-1433, Masdeu,J.C.,et al, 2000

Practice Parameter: The Usefulness of Evoked Potentials in Identifying Clinically Silent Lesions in Patients With Suspected Multiple Sclerosis (an Evidence-Based Review)
Neurol 54:1720-1725, Gronseth,G.S.&Ashman,E.J., 2000

Cerebrospinal Fluid Oligoclonal IgG Bands in Patients With Spinal Arteriovenous Malformation and Structural Central Nervous System Lesions
Arch Neurol 57:553-557, Cohen,O.,et al, 2000

Neurologic and Developmental Disability After Extremely Preterm Birth
NEJM 343:378-384,429, Wood,N.S. et al, 2000

Clinicopath Conf, Neurocysticercosis, Left Temporal Lobe, End-Stage with Calicification, Epilepsy
NEJM 343:420-427, Case 24-2000, 2000

Functional Outcomes After Gamma Knife Thalamotomy for Essential Tremor and MS-Related Tremor
Neurol 55:443-446, Niranjan,A. et al, 2000

Poliomyelitic-Like Illness in Central European Encephalitis
Neurol 55:299-302, Schellinger,P.D. et al, 2000

Optic Neuritis in Multiple Sclerosis: An Update
The Neurologist 6:205-213, Chan,J.W., 2000

Inborn Errors of Metabolism as a Cause of Neurological Disease in Adults: An Approach to Investigation
JNNP 69: 5-12, Gray,R.G.F. et al, 2000

Disability in Young People and Adults One Year after Head Injury: Prospective Cohort Study
BMJ 320:1631-1635, Thornhill,S. et al, 2000

Trauma Does Not Precipitate Multiple Sclerosis
Arch Neurol 57:1077-1078, Cook.S.D., 2000

Trauma to the Central Nervous System May Result in Formation or Enlargement of Multiple Sclerosis Plaques
Arch Neurol 57:1074-1076,1078, Poser,C.M., 2000

Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000

Psychological Stress and the Subsequent Appearance of New Brain MRI Lesions in MS
Neurol 55:55-61, Mohr,D.C. et al, 2000

Injections of Botulinum Toxin A Into the Salivary Glands Improve Sialorrhoea in Amyotrophic Lateral Sclerosis
JNNP 69:121-123, Giess,R. et al, 2000

Acute Aphasia in Multiple Sclerosis
Arch Neurol 57:1207-1209, Devere,T.R. et al, 2000

Health-Related Quality of Life in Neurology
Arch Neurol 57:1224-1227, Meyers,A.R. et al, 2000

What Contributes to Quality of Life in Patients with Parkinson's Disease?
JNNP 69:308-312,289, Schrag,A. et al, 2000

Cerebral Infarctin in the Term Newborn: Clinical Presentation and Long-Term Outcome
J Pediatr 137:351-355, Sreenan,C. et al, 2000

Multiple Sclerosis
NEJM 343:938-952, Noseworthy,J.H. et al, 2000

Intramuscular Interferon Beta-1a Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis
NEJM 343:898-904, Jacobs,L.D. et al, 2000

Relapses and Progression of Disability in Multiple Sclerosis
NEJM 343:1430-1438,1486, Confavreux,C.,et al, 2000

Linkage of Familial Amyotrophic Lateral Sclerosis with Frontotemporal Dementia to Chromosome 9q21-q22
JAMA 284:1664-1669, Hosler,B.A.,et al, 2000

A 44-Year-Old Woman with Difficulty Walking
JAMA 284:2632-2639, Iezzoni,L.I., 2000

The Clinical Spectrum of Anti-GAD Antibody-Positive Patients with Stiff-Person Syndrome
Neurol 55:1531-1535, Dalakas,M.C.,et al, 2000

Conjugal Multiple Sclerosis: Population-Based Prevalence and Recurrence Risks in Offspring
Ann Neurol 48:927-931, Evers,G.C.,et al, 2000

Relative Contributions of Brain and Cervical Cord Pathology to Multiple Sclerosis Disability: a Study with Magnetisation Transfer Ratio Histogram Analysis
JNNP 69:723-727, Rovaris,M.,et al, 2000

Topiramate Relieves Refractory Trigeminal Neuralgia in MS Patients
Neurol 55:1587-1588, Zvartau-Hind,M.,et al, 2000

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR 21:702-706, Tintore,M.,et al, 2000

De Novo Mutation in the Notch3 Gene Causing CADASIL
Ann Neurol 47:388-391, Joutel,A.,et al, 2000

TI-201 SPECT in Pseudotumoral Multiple Sclerosis
Clin Nucl Med 24:186-188, Obach,V.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999

Botulinum Toxin is a Useful Treatment in Excessive Drooling of Saliva
JNNP 67:697, Bhatia,K.P.,et al, 1999

Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999

Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999

Utilization of Unconventional Treatments by Persons with MS:Is It Alternative or Complementary?
Neurol 52:626-629, Schwartz,C.E.,et al, 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Suppression of Pendular Nystagmus by Smoking Cannabis in a Patient with Multiple Sclerosis
Neurol 53:2209-2210, Schon,F.,et al, 1999

Gastric Tolerance of High-Dose Pulse Oral Prednisone in Multiple Sclerosis
Neurol 53:2093-2096, Metz,L.M.,et al, 1999

Magnetization Transfer Imaging of Patients with Definite MS and Negative Conventional MRI
Neurol 52:845-848, Filippi,M.,et al, 1999

Primary and Transitional Progressive MS,A Clinical and MRI Cross-Sectional Study
Neurol 52:839-845, Stevenson,V.L.,et al, 1999

Development of Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Images in Multiple Sclerosis,Relation to Inflammatory Activity
Arch Neurol 56:345-351, van Walderveen,M.A.A.,et al, 1999



Showing articles 1050 to 1100 of 2500 << Previous Next >>